IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 157 to 168 of 461

26 January 2018

IDPC analysis of the UNODC World Drug Report 2017

This year’s report, which includes content like interactive maps and data sets, is one of the agency’s most thorough and accessible publications to date.

15 January 2018

What comes next? Post-UNGASS options for 2019 - Version 4

IDPC suggests avenues to ensure that the outcome of the 2019 High Level Ministerial Segment reflects international commitments and debates.

23 November 2017

Drug laws in West Africa: A review and summary

IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.

2 November 2017

IDPC contribution for the pre-review of CBD and Tramadol at the 39th WHO Expert Committee on Drug Dependence

In this advocacy note, IDPC offers some analysis and key recommendations on CBD and tramadol to inform the ECDD’s meeting set to take place in November 2017.

2 November 2017

IDPC contribution for the upcoming report of the Office of the High Commissioner for Human Rights (OHCHR) on 'Civil society space in multilateral institutions'

IDPC reviews the successes and obstacles of civil society participation in the 2016 UNGASS as a case study to feed into the upcoming OHCHR report.

2 November 2017

IDPC progress report 2016-2017

This IDPC progress report provides an overview of our activities between 2016 and 2017, including our continuing efforts to build capacity for drug policy advocacy and the numerous publications and resources produced during this period.

27 October 2017

IDPC contribution for the upcoming report of the Office of the High Commissioner for Human Rights (OHCHR) on the Sustainable Development Goals and Health

IDPC calls upon the OHCHR to promote harm reduction, reiterate its call for the decriminalisation of drug use and end all other forms of inhumane and disproportionate punishment.

28 September 2017

Edging forward: How the UN’s language on drugs has advanced since 1990

In an effort to help digest and contextualise the UNGASS Outcome Document, this IDPC briefing paper explores a selection of key themes by analysing the consensus-based language agreed by UN member states during high-level meetings over the last quarter of a century.

25 September 2017

IDPC response to the INCB Annual Report for 2016

IDPC analyses some key aspects of the INCB report, focusing on the Foreword, the thematic chapter on women and drugs and the INCB's approach towards health, human rights and cannabis regulation.

21 September 2017

Política de Drogas na África: Rumo a uma abordagem baseada em direitos humanos

Esta nota para advocacia pretende dar uma visão geral não exaustiva de como as políticas de droga violam os direitos humanos universais e o que é, na prática, uma abordagem de direitos, com base na Carta de Banjul.

16 August 2017

English Harm Reduction Group response to the 2017 UK Drug Strategy

The English Harm Reduction Group have published a statement, strongly condemning the absence of harm reduction in the UK Drug Strategy, despite dramatically increasing numbers of drug-related deaths.

19 July 2017

The 2017 Commission on Narcotic Drugs: Report of Proceedings

IDPC discusses the key issues and debates that took place at the first since the UNGASS of 2016.